Observational Study for the Evaluation of Incidence of Systemic Mastocytosis in t(8;21) Acute Myeloid Leukemia

计划入组 200 人 · 首次发布于 2022 年 8 月 17 日

Dasatinib Combined With Chemotherapy in Relapsed t(8;21) Acute Myeloid Leukemia With KIT D816 Mutation

首次发布于 2018 年 6 月 18 日

Phenylbutyrate, Dexamethasone, and Sargramostim in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia

首次发布于 2003 年 7 月 28 日

Acute Myeloid Leukemia(Advesya)

DCPS inhibitor (acute myeloid leukemia)

MYELOID THERAPEUTICS

United States

JAPAN ADULT LEUKEMIA STUDY GROUP

Japan

Bio-Path Holdings

United States

CD19 CAR-T Cell Therapy Shows Promise in Relapsed t(8;21) AML Despite Short-Term Remission

Hemogenyx Raises £2.5M to Advance CAR-T Therapy for Acute Myeloid Leukemia

Hemogenyx Initiates First Human Dosing of CAR-T Therapy for Resistant Acute Myeloid Leukemia